ArticleOncoimmunology

Acute tubulointerstitial nephritis associated with atezolizumab, an anti-programmed death-ligand 1 (pd-l1) antibody therapy.

M Xipell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.